Novartis AG
99.36
0.09 (0.09%)
At close: Jan 14, 2025, 3:59 PM
98.57
-0.79%
Pre-market Jan 15, 2025, 05:06 AM EST

Novartis AG Revenue Breakdown

Quarter Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019
Top 20 products Revenue 8.79B 8.26B 8.23B 7.10B 2.12B
Top 20 products Revenue Growth +6.39% +0.34% +15.91% +235.09% n/a
Rest of portfolio Revenue 2.45B 2.20B 2.33B 2.08B 7.21B
Rest of portfolio Revenue Growth +11.55% -5.42% +11.56% -71.08% n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Americas Revenue 21.54B 20.46B 2.57B 2.44B 852.00M
Americas Revenue Growth +5.24% +695.30% +5.36% +186.62% n/a
China Revenue 3.13B 3.05B 2.44B 4.12B 2.71B
China Revenue Growth +2.49% +24.98% -40.73% +52.31% n/a
Country Of Domicile Revenue 970.00M 873.00M 4.52B 2.66B 4.18B
Country Of Domicile Revenue Growth +11.11% -80.68% +70.11% -36.52% n/a
France Revenue 2.26B 2.52B 2.80B n/a 3.17B
France Revenue Growth -10.51% -10.06% n/a n/a n/a
Germany Revenue 4.28B 4.87B n/a n/a 22.17B
Germany Revenue Growth -12.16% n/a n/a n/a n/a
Japan Revenue 2.21B 2.68B n/a n/a n/a
Japan Revenue Growth -17.82% n/a n/a n/a n/a
Other Countries Revenue 20.05B 20.81B n/a n/a n/a
Other Countries Revenue Growth -3.62% n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 3.13B 3.09B 2.84B 3.44B 3.09B 3.69B 3.44B 3.75B 3.41B 3.58B 3.51B 3.98B 3.62B 3.75B 3.53B 3.92B 3.42B 3.37B 3.49B 3.90B 3.55B 3.58B 3.33B 4.40B 3.26B 4.19B 3.92B 4.04B 3.68B 3.81B 3.47B 3.84B 3.40B 3.65B 3.31B 3.88B 3.46B 3.62B 3.28B
Selling, General, and Administrative Revenue Growth +1.39% +8.84% -17.54% +11.42% -16.14% +7.06% -8.11% +9.79% -4.69% +1.96% -11.87% +10.14% -3.62% +6.38% -10.07% +14.77% +1.51% -3.38% -10.73% +10.03% -1.00% +7.66% -24.39% +35.05% -22.23% +6.88% -2.92% +9.87% -3.36% +9.62% -9.54% +12.88% -6.82% +10.41% -14.93% +12.19% -4.26% +10.21% n/a
Research and Development Revenue 2.39B 2.28B 2.23B 2.57B 3.92B 2.53B 2.79B 2.44B 2.74B 2.50B 2.32B 2.41B 2.38B 2.40B 2.35B 2.33B 2.15B 2.44B 2.06B 2.85B 2.20B 2.05B 2.30B 2.40B 2.15B 2.28B 2.12B 2.50B 2.24B 2.06B 2.17B 2.58B 2.22B 2.19B 2.04B 2.47B 2.19B 2.21B 2.07B
Research and Development Revenue Growth +5.10% +2.06% -13.13% -34.60% +55.38% -9.59% +14.41% -10.75% +9.53% +7.67% -3.69% +1.22% -0.83% +2.08% +0.77% +8.71% -12.09% +18.50% -27.80% +29.74% +7.22% -10.79% -4.17% +11.74% -5.67% +7.36% -15.27% +11.75% +8.58% -4.93% -16.06% +16.19% +1.55% +7.30% -17.44% +12.88% -0.73% +6.72% n/a

Create Price Alert on NVS

Your price alert will notify you when the stock price is above 99.36.

Add to Watchlist